Literature DB >> 28168427

RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration.

Kazimierz Gąsiorowski1, Barbara Brokos1, Valentina Echeverria2, George E Barreto3,4, Jerzy Leszek5.   

Abstract

Chronic inflammatory reactions are consistenly present in neurodegeneration of Alzheimer type and are considered important factors that accelerate progression of the disease. Receptors of innate immunity participate in triggering and driving inflammatory reactions. For example, Toll-like receptors (TLRs) and receptor for advanced glycation end product (RAGE), major receptors of innate immunity, play a central role in perpetuation of inflammation. RAGE activation should be perceived as a primary mechanism which determines self-perpetuated chronic inflammation, and RAGE cooperation with TLRs amplifies inflammatory signaling. In this review, we highlight and discuss that RAGE-TLR crosstalk emerges as an important driving force of chronic inflammation in Alzheimer's disease.

Entities:  

Keywords:  Chronic inflammation; Neurodegeneration; Rage; Self-perpetuated stimulation; TLR

Mesh:

Substances:

Year:  2017        PMID: 28168427     DOI: 10.1007/s12035-017-0419-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  124 in total

1.  Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.

Authors:  A Taguchi; D C Blood; G del Toro; A Canet; D C Lee; W Qu; N Tanji; Y Lu; E Lalla; C Fu; M A Hofmann; T Kislinger; M Ingram; A Lu; H Tanaka; O Hori; S Ogawa; D M Stern; A M Schmidt
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

2.  Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.

Authors:  K Ohashi; V Burkart; S Flohé; H Kolb
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

Review 3.  Innate immunity in Alzheimer's disease.

Authors:  Michael T Heneka; Douglas T Golenbock; Eicke Latz
Journal:  Nat Immunol       Date:  2015-03       Impact factor: 25.606

4.  Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production.

Authors:  R Clancy; B Varenika; W Huang; L Ballou; M Attur; A R Amin; S B Abramson
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

5.  Preferential expression and function of Toll-like receptor 3 in human astrocytes.

Authors:  Cinthia Farina; Markus Krumbholz; Thomas Giese; Gunther Hartmann; Francesca Aloisi; Edgar Meinl
Journal:  J Neuroimmunol       Date:  2004-11-11       Impact factor: 3.478

Review 6.  Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment.

Authors:  Maria Serpente; Rossana Bonsi; Elio Scarpini; Daniela Galimberti
Journal:  Neuroimmunomodulation       Date:  2014-02-14       Impact factor: 2.492

7.  N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.

Authors:  Xavier Gironès; Arantxa Guimerà; Celia-Z Cruz-Sánchez; Arantxa Ortega; Noboyuki Sasaki; Zenji Makita; José Vivente Lafuente; Raj Kalaria; Félix F Cruz-Sánchez
Journal:  Free Radic Biol Med       Date:  2004-05-15       Impact factor: 7.376

8.  Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease.

Authors:  Miles C Miller; Rosemarie Tavares; Conrad E Johanson; Virginia Hovanesian; John E Donahue; Liliana Gonzalez; Gerald D Silverberg; Edward G Stopa
Journal:  Brain Res       Date:  2008-07-14       Impact factor: 3.252

Review 9.  Nuclear factor-κB, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect.

Authors:  Renée F Johnson; Neil D Perkins
Journal:  Trends Biochem Sci       Date:  2012-05-23       Impact factor: 13.807

10.  RAGE mediated intracellular Aβ uptake contributes to the breakdown of tight junction in retinal pigment epithelium.

Authors:  Sung Wook Park; Jin Hyoung Kim; Sang Min Park; Minho Moon; Ki Hwang Lee; Kyu Hyung Park; Woo Jin Park; Jeong Hun Kim
Journal:  Oncotarget       Date:  2015-11-03
View more
  26 in total

1.  sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation.

Authors:  Soyeon Lim; Myung Eun Lee; Jisu Jeong; Jiye Lee; Soyoung Cho; Miran Seo; Sungha Park
Journal:  Inflamm Res       Date:  2018-05-23       Impact factor: 4.575

2.  Inhibiting Effect of Zinc Oxide Nanoparticles on Advanced Glycation Products and Oxidative Modifications: a Potential Tool to Counteract Oxidative Stress in Neurodegenerative Diseases.

Authors:  Jalaluddin M Ashraf; Mohammad Azam Ansari; Sana Fatma; Saleh M S Abdullah; Johar Iqbal; Aymen Madkhali; Al Hassan Hamali; Saheem Ahmad; Ahmed Jerah; Valentina Echeverria; George E Barreto; Ghulam Md Ashraf
Journal:  Mol Neurobiol       Date:  2018-02-08       Impact factor: 5.590

Review 3.  Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity.

Authors:  Charles W Frevert; Jessica Felgenhauer; Malgorzata Wygrecka; Madalina V Nastase; Liliana Schaefer
Journal:  J Histochem Cytochem       Date:  2018-01-01       Impact factor: 2.479

4.  Fimbristylis ovata and Artemisia vulgaris extracts inhibited AGE-mediated RAGE expression, ROS generation, and inflammation in THP-1 cells.

Authors:  Suporn Sukjamnong; Hui Chen; Sonia Saad; Rachana Santiyanont
Journal:  Toxicol Res       Date:  2022-01-30

Review 5.  The Role of Polyphenol in Modulating Associated Genes in Diabetes-Induced Vascular Disorders.

Authors:  Nor Anizah Mohd Nor; Siti Balkis Budin; Satirah Zainalabidin; Juriyati Jalil; Syaifuzah Sapian; Fatin Farhana Jubaidi; Nur Najmi Mohamad Anuar
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

Review 6.  Role of high mobility group box protein 1 in depression: A mechanistic and therapeutic perspective.

Authors:  Shu Wang; Yu-Guang Guan; Yan-Hua Zhu; Min-Zhong Wang
Journal:  World J Psychiatry       Date:  2022-06-19

7.  Nonhuman Primate Models of Neurodegenerative Disorders.

Authors:  Marina E Emborg
Journal:  ILAR J       Date:  2017-12-01

Review 8.  Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors.

Authors:  Hyeon Jin Kim; Mi Suk Jeong; Se Bok Jang
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

9.  Therapeutic Effectiveness of Anti-RAGE Antibody Administration in a Rat Model of Crush Injury.

Authors:  Hisatake Matsumoto; Naoya Matsumoto; Junya Shimazaki; Junichiro Nakagawa; Yukio Imamura; Kazuma Yamakawa; Tomoki Yamada; Mitsunori Ikeda; Hiroko Hiraike; Hiroshi Ogura; Takeshi Shimazu
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

10.  Elevated Plasma Level of Soluble Form of RAGE in Ischemic Stroke Patients with Dementia.

Authors:  Sung-Chun Tang; Kai-Chien Yang; Chaur-Jong Hu; Hung-Yi Chiou; Chau Chung Wu; Jiann-Shing Jeng
Journal:  Neuromolecular Med       Date:  2017-11-02       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.